E

Evolus
D

EOLS

4.84000
USD
-0.08
(-1.63%)
مغلق
حجم التداول
28,289
الربح لكل سهم
0
العائد الربحي
-
P/E
-6
حجم السوق
313,727,755
أصول ذات صلة المقالات

العنوان: Evolus

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.